Because it targets a host protein and therefore does not induce viral resistance, DEB025 has the potential to be added to any HCV cocktail—with or without interferon—as long as it does not cause overlapping toxicity.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”